BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34340701)

  • 1. Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women.
    Cairat M; Al Rahmoun M; Gunter MJ; Heudel PE; Severi G; Dossus L; Fournier A
    BMC Med; 2021 Aug; 19(1):186. PubMed ID: 34340701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women.
    Cairat M; Al Rahmoun M; Gunter MJ; Severi G; Dossus L; Fournier A
    Breast Cancer Res; 2020 Oct; 22(1):118. PubMed ID: 33129324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women.
    Cairat M; Al Rahmoun M; Gunter MJ; Severi G; Dossus L; Fournier A
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):643-652. PubMed ID: 33531438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM; Pfeiffer RM; Gierach GL; Falk RT
    Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifiable risk factors for advanced vs. early breast cancer in the French E3N cohort.
    Veron L; Gelot A; Gusto G; Arveux P; Delaloge S; Boutron-Ruault MC
    Int J Cancer; 2020 Feb; 146(3):850-860. PubMed ID: 31001839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
    Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
    Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.
    Fournier A; Mesrine S; Gelot A; Fagherazzi G; Baglietto L; Clavel-Chapelon F; Boutron-Ruault MC; Chabbert-Buffet N
    J Clin Oncol; 2017 Oct; 35(28):3230-3239. PubMed ID: 28708471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study.
    Cottet V; Touvier M; Fournier A; Touillaud MS; Lafay L; Clavel-Chapelon F; Boutron-Ruault MC
    Am J Epidemiol; 2009 Nov; 170(10):1257-67. PubMed ID: 19828509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent recreational physical activity and breast cancer risk in postmenopausal women in the E3N cohort.
    Fournier A; Dos Santos G; Guillas G; Bertsch J; Duclos M; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1893-902. PubMed ID: 25114017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
    Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
    Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
    Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
    Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.
    Ma H; Henderson KD; Sullivan-Halley J; Duan L; Marshall SF; Ursin G; Horn-Ross PL; Largent J; Deapen DM; Lacey JV; Bernstein L
    Breast Cancer Res; 2010; 12(3):R35. PubMed ID: 20565829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Energy Density and Postmenopausal Breast Cancer Incidence in the Cancer Prevention Study II Nutrition Cohort.
    Hartman TJ; Gapstur SM; Gaudet MM; Shah R; Flanders WD; Wang Y; McCullough ML
    J Nutr; 2016 Oct; 146(10):2045-2050. PubMed ID: 27629577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
    Dartois L; Fagherazzi G; Baglietto L; Boutron-Ruault MC; Delaloge S; Mesrine S; Clavel-Chapelon F
    Int J Cancer; 2016 May; 138(10):2415-27. PubMed ID: 26756677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
    Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
    Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Television Viewing Time and Breast Cancer Incidence for Japanese Premenopausal and Postmenopausal Women: The JACC Study.
    Cao J; Eshak ES; Liu K; Muraki I; Cui R; Iso H; Tamakoshi A;
    Cancer Res Treat; 2019 Oct; 51(4):1509-1517. PubMed ID: 30913861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.